Target Price | $43.20 |
Price | $37.02 |
Potential | 16.69% |
Number of Estimates | 15 |
15 Analysts have issued a price target Exelon 2025 . The average Exelon target price is $43.20. This is 16.69% higher than the current stock price. The highest price target is $47.00 26.96% , the lowest is $39.00 5.35% . | |
A rating was issued by 21 analysts: 6 Analysts recommend Exelon to buy, 14 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Exelon stock has an average upside potential 2025 of 16.69% . Most analysts recommend the Exelon stock at Hold. |
11 Analysts have issued a sales forecast Exelon 2024 . The average Exelon sales estimate is $21.9b . This is 4.63% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $23.0b 0.52% , the lowest is $19.9b 13.29% .
This results in the following potential growth metrics:
2023 | $21.7b | 13.89% |
---|---|---|
2024 | $21.9b | 0.64% |
2025 | $22.6b | 3.51% |
2026 | $23.4b | 3.24% |
2027 | $23.8b | 1.76% |
2028 | $24.2b | 1.65% |
9 Analysts have issued an Exelon EBITDA forecast 2024. The average Exelon EBITDA estimate is $8.3b . This is 5.23% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $8.5b 8.25% , the lowest is $7.9b 0.63% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | $7.5b | 9.65% |
---|---|---|
2024 | $8.3b | 9.68% |
2025 | $8.9b | 7.51% |
2026 | $9.5b | 6.91% |
2027 | $10.4b | 9.07% |
2028 | $11.0b | 6.26% |
2023 | 34.74% | 3.72% |
---|---|---|
2024 | 37.86% | 8.98% |
2025 | 39.32% | 3.86% |
2026 | 40.72% | 3.56% |
2027 | 43.65% | 7.20% |
2028 | 45.63% | 4.54% |
6 Exelon Analysts have issued a net profit forecast 2024. The average Exelon net profit estimate is $2.5b . This is 1.21% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.5b 2.47% , the lowest is $2.5b 0.63% .
This results in the following potential growth metrics and future Net Margins:
2023 | $2.4b | 6.36% |
---|---|---|
2024 | $2.5b | 5.11% |
2025 | $2.7b | 7.22% |
2026 | $2.8b | 5.05% |
2027 | $3.0b | 6.67% |
2028 | $3.1b | 5.63% |
2023 | 10.82% | 6.60% |
---|---|---|
2024 | 11.30% | 4.40% |
2025 | 11.71% | 3.63% |
2026 | 11.92% | 1.79% |
2027 | 12.49% | 4.78% |
2028 | 12.98% | 3.92% |
6 Analysts have issued a Exelon forecast for earnings per share. The average Exelon <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $2.46 . This is 1.23% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $2.49 2.47% , the lowest is $2.45 0.82% .
This results in the following potential growth metrics and future valuations:
2023 | $2.34 | 6.36% |
---|---|---|
2024 | $2.46 | 5.13% |
2025 | $2.64 | 7.32% |
2026 | $2.77 | 4.92% |
2027 | $2.96 | 6.86% |
2028 | $3.12 | 5.41% |
Current | 15.26 | 7.63% |
---|---|---|
2024 | 15.05 | 1.38% |
2025 | 14.04 | 6.71% |
2026 | 13.36 | 4.84% |
2027 | 12.53 | 6.21% |
2028 | 11.86 | 5.35% |
Based on analysts' sales estimates for 2024, the Exelon stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 3.76 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 1.70 .
This results in the following potential growth metrics and future valuations:
Current | 3.58 | 3.24% |
---|---|---|
2024 | 3.76 | 4.89% |
2025 | 3.63 | 3.39% |
2026 | 3.51 | 3.14% |
2027 | 3.45 | 1.73% |
2028 | 3.40 | 1.62% |
Current | 1.62 | 3.42% |
---|---|---|
2024 | 1.70 | 4.85% |
2025 | 1.64 | 3.39% |
2026 | 1.59 | 3.14% |
2027 | 1.56 | 1.73% |
2028 | 1.54 | 1.62% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.